BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 2878541)

  • 1. [Significance of endothelial cells for the regulation of the tone of smooth muscle--formation of an endothelial, relaxing factor].
    Förstermann U
    Z Kardiol; 1986 Oct; 75(10):577-83. PubMed ID: 2878541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties and mechanisms of production and action of endothelium-derived relaxing factor.
    Förstermann U
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S45-51. PubMed ID: 2438490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of vascular tone by the endothelium].
    Busse R; Bassenge E
    Z Kardiol; 1985; 74 Suppl 7():99-106. PubMed ID: 3004057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction and vascular disease.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1998; 60(3):251-66. PubMed ID: 9803882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium-derived relaxing and contracting factors.
    Rubanyi GM
    J Cell Biochem; 1991 May; 46(1):27-36. PubMed ID: 1874796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
    Waldman SA; Murad F
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
    Kanamaru K; Waga S; Kojima T; Fujimoto K
    No To Shinkei; 1989 Jun; 41(6):559-65. PubMed ID: 2553081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelial functions in cardiovascular diseases].
    Mügge A; Förstermann U; Lichtlen PR
    Z Kardiol; 1989 Mar; 78(3):147-60. PubMed ID: 2652905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-derived relaxing and contracting factors.
    Furchgott RF; Vanhoutte PM
    FASEB J; 1989 Jul; 3(9):2007-18. PubMed ID: 2545495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
    Martin W; Furchgott RF; Villani GM; Jothianandan D
    J Pharmacol Exp Ther; 1986 May; 237(2):529-38. PubMed ID: 3009791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The L-arginine-NO pathway and cyclic GMP in the vessel wall.
    Stoclet JC
    Z Kardiol; 1991; 80 Suppl 7():87-90. PubMed ID: 1665267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
    MacLeod KM; Ng DD; Harris KH; Diamond J
    Mol Pharmacol; 1987 Jul; 32(1):59-64. PubMed ID: 2885738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
    Bassenge E; Busse R; Pohl U
    Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.